Compound Evidence File
#EC-2026-0794
Cagrilintide 5mg + Semaglutide 5mg Blend
Filed under Peptides. The bureau holds 209 laboratory returns for this compound from 86 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
86 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 4 | 10.0 | 9.9 | 10.0 | 23 May 2026 | 23 May 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 4 | 10.0 | 10.0 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 4 | 10.0 | 9.9 | 10.0 | 1 Dec 2025 | 17 Jun 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 4 | 10.0 | 10.0 | 10.0 | 4 May 2026 | 16 Jun 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 4 | 10.0 | 10.0 | 10.0 | 25 Apr 2026 | 3 Jul 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 3 | 10.0 | 10.0 | 10.0 | 11 Jan 2026 | 3 Jul 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 3 | 10.0 | 9.9 | 10.0 | 6 Mar 2026 | 5 May 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 3 | 10.0 | 9.9 | 10.0 | 17 Jan 2026 | 18 Jul 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 3 | 10.0 | 9.9 | 10.0 | 24 Feb 2026 | 26 Apr 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 2 | 10.0 | 10.0 | 10.0 | 27 Apr 2026 | 21 Jun 2026 |
| PeptiAtlasCASE #VI-2026-0739 | X | 1 | 10.0 | 10.0 | 10.0 | 28 Mar 2025 | 28 Mar 2025 |
| Xianhong Tong XHT PeptidesCASE #VI-2026-0997 | X | 1 | 10.0 | 10.0 | 10.0 | 27 Feb 2025 | 27 Feb 2025 |
| Paradigm PeptideCASE #VI-2026-0759 | X | 1 | 10.0 | 10.0 | 10.0 | 3 Jul 2025 | 3 Jul 2025 |
| Lux Synth AminosCASE #VI-2026-0700 | X | 1 | 10.0 | 10.0 | 10.0 | 6 May 2025 | 6 May 2025 |
| Bfflist AMOCASE #VI-2026-0678 | X | 1 | 10.0 | 10.0 | 10.0 | 16 Mar 2025 | 16 Mar 2025 |
| Laicuinuo LCNCASE #VI-2026-0223 | X | 1 | 10.0 | 10.0 | 10.0 | 14 Jan 2025 | 14 Jan 2025 |
| BachemCASE #VI-2026-0314 | A | 4 | 9.9 | 9.9 | 10.0 | 11 Nov 2025 | 13 May 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 4 | 9.9 | 9.9 | 10.0 | 1 Feb 2026 | 1 Jul 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 4 | 9.9 | 9.9 | 10.0 | 23 Mar 2026 | 7 Jul 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 4 | 9.9 | 9.9 | 10.0 | 8 Jan 2026 | 15 Jun 2026 |
| SinoPepCASE #VI-2026-0387 | A | 4 | 9.9 | 9.9 | 10.0 | 23 Mar 2026 | 3 Aug 2026 |
| AsymchemCASE #VI-2026-0091 | A | 4 | 9.9 | 9.9 | 10.0 | 20 Feb 2026 | 8 Jun 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 3 | 9.9 | 9.9 | 10.0 | 5 Jan 2026 | 6 Jul 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 3 | 9.9 | 9.9 | 9.9 | 20 Mar 2026 | 6 Jul 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 3 | 9.9 | 9.9 | 10.0 | 10 May 2026 | 14 Jul 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 3 | 9.9 | 9.9 | 10.0 | 25 Dec 2025 | 19 Jun 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 2 | 9.9 | 9.9 | 9.9 | 10 Mar 2026 | 18 Apr 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 2 | 9.9 | 9.9 | 10.0 | 19 Feb 2026 | 13 Jun 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 2 | 9.9 | 9.9 | 9.9 | 2 May 2026 | 8 Jun 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 2 | 9.1 | 8.2 | 10.0 | 24 May 2026 | 24 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 6 | 8.8 | 7.6 | 10.0 | 24 May 2026 | 24 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 2 | 8.6 | 8.6 | 8.7 | 23 May 2026 | 23 May 2026 |
| Mai PeptideCASE #VI-2026-0769 | X | 3 | 8.5 | 7.5 | 9.5 | 7 May 2025 | 21 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 6 | 8.4 | 6.7 | 9.8 | 24 May 2026 | 24 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 4 | 8.3 | 7.9 | 8.7 | 21 May 2026 | 21 May 2026 |
| Bulk Peptide WholesaleCASE #VI-2026-0319 | A | 2 | 8.2 | 8.2 | 8.2 | 6 May 2025 | 21 May 2026 |
| Precision Peptide CoCASE #VI-2026-0559 | X | 2 | 8.2 | 7.2 | 9.2 | 25 Apr 2025 | 20 May 2026 |
| Yiwu Aozuo Trading CoCASE #VI-2026-0798 | X | 9 | 8.1 | 5.9 | 10.0 | 11 Jun 2025 | 25 May 2026 |
| The Naughty NeedleCASE #VI-2026-0432 | X | 1 | 8.0 | 8.0 | 8.0 | 11 Jun 2025 | 11 Jun 2025 |
| Orbitrex PeptidesCASE #VI-2026-0812 | X | 1 | 8.0 | 8.0 | 8.0 | 3 Jul 2025 | 3 Jul 2025 |
| TCICASE #VI-2026-0650 | X | 1 | 8.0 | 8.0 | 8.0 | 20 Jun 2025 | 20 Jun 2025 |
| Peptide-SCASE #VI-2026-0111 | X | 11 | 7.8 | 4.9 | 10.0 | 11 Jun 2025 | 20 May 2026 |
| Peptide SciencesCASE #VI-2026-0867 | X | 3 | 7.8 | 6.2 | 9.4 | 3 Jul 2025 | 25 May 2026 |
| TSC Top Supplements ChinaCASE #VI-2026-0523 | X | 3 | 7.8 | 7.3 | 8.5 | 3 Jul 2025 | 21 May 2026 |
| Hangzhou Mandy BiotechnologyCASE #VI-2026-0695 | X | 1 | 7.8 | 7.8 | 7.8 | 2 Apr 2025 | 2 Apr 2025 |
| Qingdao Saber Technology Pharma QSTCASE #VI-2026-0467 | X | 1 | 7.7 | 7.7 | 7.7 | 9 Jun 2025 | 9 Jun 2025 |
| Xingtai Jiachuang TechnologyCASE #VI-2026-0712 | X | 3 | 7.5 | 6.4 | 8.6 | 3 Jul 2025 | 21 May 2026 |
| Peptide WorldwideCASE #VI-2026-0217 | X | 1 | 7.5 | 7.5 | 7.5 | 2 Jul 2025 | 2 Jul 2025 |
| Tianjin Ruiwang New Material Technology CoCASE #VI-2026-0192 | X | 7 | 7.4 | 5.9 | 8.7 | 3 Jun 2025 | 20 May 2026 |
| InjectifyCASE #VI-2026-0387 | X | 2 | 7.2 | 6.2 | 8.1 | 3 Jul 2025 | 19 Jan 2026 |
| Paramount PeptidesCASE #VI-2026-0550 | X | 6 | 7.1 | 5.0 | 10.0 | 14 Jan 2025 | 23 May 2026 |
| Zztai PeptideCASE #VI-2026-0192 | X | 1 | 7.1 | 7.1 | 7.1 | 14 Jan 2025 | 14 Jan 2025 |
| Simple PeptideCASE #VI-2026-0782 | X | 2 | 7.0 | 5.7 | 8.3 | 6 May 2025 | 21 May 2026 |
| Champion PeptideCASE #VI-2026-0909 | X | 1 | 7.0 | 7.0 | 7.0 | 17 Dec 2024 | 17 Dec 2024 |
| LSPLCASE #VI-2026-0523 | X | 3 | 6.9 | 4.2 | 9.8 | 25 Apr 2025 | 26 Jan 2026 |
| Amino AsylumCASE #VI-2026-0828 | X | 1 | 6.8 | 6.8 | 6.8 | 6 May 2025 | 6 May 2025 |
| LN PeptidesCASE #VI-2026-0781 | X | 2 | 6.7 | 5.3 | 8.1 | 14 Jan 2025 | 20 May 2026 |
| Peptide CraftersCASE #VI-2026-0994 | X | 2 | 6.7 | 6.3 | 7.0 | 2 Jul 2025 | 20 May 2026 |
| EHZ PeptidesCASE #VI-2026-0296 | X | 1 | 6.6 | 6.6 | 6.6 | 3 Jun 2025 | 3 Jun 2025 |
| NexaphCASE #VI-2026-0944 | X | 6 | 6.5 | 4.8 | 7.7 | 11 Jun 2025 | 26 Jan 2026 |
| Royal PeptidesCASE #VI-2026-0264 | X | 1 | 6.5 | 6.5 | 6.5 | 6 May 2025 | 6 May 2025 |
| Pure Tested PeptidesCASE #VI-2026-0225 | X | 1 | 6.5 | 6.5 | 6.5 | 2 Jul 2025 | 2 Jul 2025 |
| Haikou Mingheng TechnologyCASE #VI-2026-0250 | X | 1 | 6.5 | 6.5 | 6.5 | 3 Jul 2025 | 3 Jul 2025 |
| Elite Research USACASE #VI-2026-0267 | X | 3 | 6.4 | 4.5 | 8.1 | 16 Mar 2025 | 24 May 2026 |
| Dankang BioHealthCASE #VI-2026-0775 | X | 1 | 6.4 | 6.4 | 6.4 | 3 Jul 2025 | 3 Jul 2025 |
| TydesCASE #VI-2026-0493 | X | 3 | 6.0 | 4.6 | 7.4 | 7 May 2025 | 21 May 2026 |
| Limitless Life NootropicsCASE #VI-2026-0980 | X | 1 | 5.9 | 5.9 | 5.9 | 20 Jun 2025 | 20 Jun 2025 |
| Shandong Nuoweiou Medical Technology CoCASE #VI-2026-0076 | X | 1 | 5.6 | 5.6 | 5.6 | 17 Dec 2024 | 17 Dec 2024 |
| Quenna PMQCASE #VI-2026-0415 | X | 1 | 5.4 | 5.4 | 5.4 | 7 May 2025 | 7 May 2025 |
| Zenith Jove Peptide ZJCASE #VI-2026-0570 | X | 1 | 5.3 | 5.3 | 5.3 | 2 Apr 2025 | 2 Apr 2025 |
| DeuschemCASE #VI-2026-0004 | X | 1 | 5.1 | 5.1 | 5.1 | 3 Jun 2025 | 3 Jun 2025 |
| Zhang TYCASE #VI-2026-0070 | X | 1 | 4.9 | 4.9 | 4.9 | 21 May 2025 | 21 May 2025 |
| Pure RawzCASE #VI-2026-0767 | X | 1 | 4.7 | 4.7 | 4.7 | 9 Jun 2025 | 9 Jun 2025 |
| Amino AmigosCASE #VI-2026-0061 | X | 1 | 4.3 | 4.3 | 4.3 | 21 May 2025 | 21 May 2025 |
| Guangzhou Lengiuanhuang CosmeticsCASE #VI-2026-0228 | X | 1 | 4.3 | 4.3 | 4.3 | 21 May 2025 | 21 May 2025 |
| Xingtai Pukelai Technology CoCASE #VI-2026-0850 | X | 1 | 4.2 | 4.2 | 4.2 | 13 Jun 2025 | 13 Jun 2025 |
| Pharma Grade PeptidesCASE #VI-2026-0208 | X | 1 | 4.0 | 4.0 | 4.0 | 21 May 2025 | 21 May 2025 |
| Biolabshop LimitedCASE #VI-2026-0832 | X | 1 | 3.7 | 3.7 | 3.7 | 13 Feb 2025 | 13 Feb 2025 |
| Shaanxi Dideu MedichemCASE #VI-2026-0499 | X | 1 | 3.6 | 3.6 | 3.6 | 14 Jan 2025 | 14 Jan 2025 |
| Suaway Lab ResearchCASE #VI-2026-0488 | X | 2 | 3.2 | 3.1 | 3.3 | 11 Jun 2025 | 25 May 2026 |
| Explicit SarmsCASE #VI-2026-0017 | X | 1 | 2.4 | 2.4 | 2.4 | 6 May 2025 | 6 May 2025 |
| Lejian Biotech PeptideCASE #VI-2026-0746 | X | 1 | 2.2 | 2.2 | 2.2 | 24 Apr 2025 | 24 Apr 2025 |
| Platinum CryoCASE #VI-2026-0406 | X | 1 | 2.0 | 2.0 | 2.0 | 13 Jun 2025 | 13 Jun 2025 |
| PepKitsCASE #VI-2026-0320 | X | 1 | 0.0 | 0.0 | 0.0 | 6 May 2025 | 6 May 2025 |
| Coffee and PeppersCASE #VI-2026-0274 | X | 1 | 0.0 | 0.0 | 0.0 | 13 Jun 2025 | 13 Jun 2025 |
| Hebei Chengtong TechnologyCASE #VI-2026-0520 | X | 1 | 0.0 | 0.0 | 0.0 | 3 Jul 2025 | 3 Jul 2025 |
Open any subject to view the batch-level evidence for Cagrilintide 5mg + Semaglutide 5mg Blend alone.